2013
DOI: 10.5604/20831862.1059606
|View full text |Cite
|
Sign up to set email alerts
|

Genes in Sport and Doping

Abstract: Genes control biological processes such as muscle production of energy, mitochondria biogenesis, bone formation, erythropoiesis, angiogenesis, vasodilation, neurogenesis, etc. DNA profiling for athletes reveals genetic variations that may be associated with endurance ability, muscle performance and power exercise, tendon susceptibility to injuries and psychological aptitude. Already, over 200 genes relating to physical performance have been identified by several research groups. Athletes’ genotyping is develop… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
43
0
4

Year Published

2014
2014
2022
2022

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 44 publications
(47 citation statements)
references
References 65 publications
0
43
0
4
Order By: Relevance
“…Its positive effect on exercise performance must be combined with effective training programs and favorable lifestyle habits for success in sports and health benefits [249]. Accordingly, one of the applications of sports genetics could be the development of predictive genetic performance tests.…”
Section: Resultsmentioning
confidence: 99%
“…Its positive effect on exercise performance must be combined with effective training programs and favorable lifestyle habits for success in sports and health benefits [249]. Accordingly, one of the applications of sports genetics could be the development of predictive genetic performance tests.…”
Section: Resultsmentioning
confidence: 99%
“…Evidence for selection of target genes comes from studies exploring the role of gene polymorphism in determining athletic performance . Potential targets for gene doping are considered Epo, IGF‐I, myostatin, vascular endothelial growth factor (VEGF), fibroblast growth factor, α actinin 3 (ACTN3), peroxisome proliferator‐activated receptor δ (PPARδ), cytosolic phosphoenolpyruvate carbohykinase (PEPCK‐C), endorphin, enkephalin, brain‐derived neurotrophic factor (BDNF) and others . IGF‐I is a very attractive candidate for gene therapy, as animal studies show increased muscle mass, accelerated muscle and nerve regeneration in IGF‐I transgenic mice models, and muscle strength response to training is influenced by IGF‐I genotype in humans .…”
Section: Other Doping Agentsmentioning
confidence: 99%
“…Several factors that might influence the steroid profile need to be taken into consideration, such as inter-individual variability of steroid synthesis and metabolism, including the UGT2B17 or ACTN3 polymorphism (Jakobsson et al, 2006;Pokrywka et al, 2013;Ahmetov et al, 2014), pregnancy, contraceptive pills, a large intake of alcohol, the administration of ketoconazole, human chorionic gonadotropin in males, inhibitors of 5-α-reductase, the influence of microorganisms existing in urine samples and the use of masking agents and diuretics (Mareck et al, 2008;World Anti-Doping Agency, 2014).…”
Section: Introductionmentioning
confidence: 99%